R Bellomo, M Egi, I Baldwin, N Fealy, M Johnstone
Journal: The International journal of artificial organs 2007;30(4):301-7
PMID: 17520566
OBJECTIVE
To evaluate the efficacy and safety of a regional heparinization and a regional citrate method of anticoagulation in CVVH.
DESIGN
Randomized controlled cross-over study.
SUBJECTS
Ten critically ill patients with acute renal failure.
SETTING
ICU of tertiary hospital.
INTERVENTION
CVVH was performed with pre-filter fluid replacement at 2000 ml/h and a blood flow rate of 150 ml/min. Regional heparinization was by the administration of heparin pre-filter at 1500 IU/h and protamine post-filter at 15 mg/h. Regional citrate anticoagulation was by means of a citrate-based replacement fluid (14 mmol/L) administered pre-dilution.
RESULTS
We studied nine males and one female. The mean age and APACHE II score were 70.5 and 17 respectively. Median circuit life was 13 hours (IQR 9.28) for the regional heparinization method compared to 17 hours (IQR 12,19.5) for the regional citrate method (p=0.77). There were no episodes of bleeding in either group.
CONCLUSION
Regional heparinization and regional citrate anticoagulation achieve similar circuit life in critically ill patients receiving CVVH.
Full Text Sources:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.